Edwards Lifesciences Corporation (EW) Draws Positive Analyst View After Q4 Update
Edwards Lifesciences Corporation (NYSE:EW) is one of the best medical technology stocks to invest in.
Edwards Lifesciences Corp (EW)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 6,080,938 | $518,399,964 | +242% | 0.22% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 5,925,627 | $505,159,711 | +67% | 0.46% |
| 3. | Holocene Advisors Brandon Haley | 2,251,043 | $191,901,416 | -53% | 0.4% |
| 4. | AQR Capital Management Cliff Asness | 2,241,751 | $191,109,205 | +8% | 0.1% |
| 5. | Citadel Investment Group Ken Griffin | 2,203,927 | $187,884,777 | -48% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $85.74 | 580 | $49,752.72 | 3,268 | 2024-05-06 | Filing | |
| $112.23 | 1,500 | $168,345.00 | 63,811 | 2021-11-24 | Filing | |
| $90.10 | 3,000 | $270,300.00 | 9,042 | 2017-02-03 | Filing | |
| $83.33 | 3,942 | $328,486.86 | 3,942 | 2016-11-30 | Filing | |
| $83.47 | 8,928 | $745,205.88 | 43,690 | 2016-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $76.61 | 19,898 | $1,524,451.44 | 83,896 | 2026-02-12 | Filing | |
| $77.13 | 2,532 | $195,289.87 | 103,794 | 2026-02-12 | Filing | |
| $85.70 | 1,019 | $87,332.07 | 22,002 | 2026-01-09 | Filing | |
| $85.98 | 8,708 | $748,707.74 | 31,870 | 2026-01-06 | Filing | |
| $84.62 | 2,632 | $222,721.42 | 40,578 | 2026-01-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 70,079,435 | $5,974,271,834 | 0.09% | |
| 2. | 52,461,915 | $4,472,378,277 | 0.08% | |
| 3. | 26,024,852 | $2,218,618,661 | 0.14% | |
| 4. | 25,991,524 | $2,215,777,421 | 0.07% | |
| 5. | 21,793,949 | $1,857,934,152 | 0.33% |
News See All
10 Best Medical Technology Stocks to Invest In
Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.
Edwards Lifesciences Corporation (NYSE:EW) Q4 2025 Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE:EW) Q4 2025 Earnings Call Transcript February 10, 2026Edwards Lifesciences Corporation misses on earnings expectations.
Edwards Lifesciences Corporation (EW): A Bull Case Theory
We came across a bullish thesis on Edwards Lifesciences Corporation on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on EW.
Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW)
Edwards Lifesciences Corporation (NYSE:EW) is one of the best healthcare stocks to buy for 2026.
12 Best Healthcare Stocks to Buy for 2026
Artificial Intelligence has been the catalyst behind the blockbuster rally in equity markets over the past two years.
Renewed Growth Cycle Drives a Favorable Sentiment Towards Edwards Lifesciences (EW)
On January 20, Adam Maeder from Piper Sandler maintained his Overweight rating on Edwards Lifesciences (NYSE:EW).
12 Best Medical Devices Stocks to Invest In According to Hedge Funds
It is challenging to identify segments within the markets that appear to be defensive plays, yet offer innovation potential.
Does Edwards Lifesciences (EW) Have Strong Double-Digit Earnings Potential?
Wedgewood Partners, an investment management company, released its fourth-quarter 2025 investor letter.
Edwards Lifesciences Corporation (NYSE:EW) Q3 2025 Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE:EW) Q3 2025 Earnings Call Transcript October 30, 2025Edwards Lifesciences Corporation beats earnings expectations.
Hedge Fund Resource Center